Rising Radonc @Moffittradonc | Internship @NorthwellHealth | @Stonybrookmed 23' | @NYIT 18'
New York, USA
Joined March 2022
- Tweets125
- Following255
- Followers171
- Likes572
Simran Polce, MD retweeted
Getting Personal: Optimizing RT Dosing Strategies for Improved Outcomes
🔗 Read more here: zurl.co/vgHVa
“Utilizing dose painting and hypofractionation is a very easy next step forward,” says Arash Naghavi, MD, associate professor of radiation oncology, section head for sarcoma, and brachytherapy fellowship program director at Moffitt Cancer Center, who has been implementing the treatment methods in patient care.
#RadOnc #RadiationOncology #CancerCare
Simran Polce, MD retweeted
Radiation Therapy in Cancer of Accessory Breast Tissue: Questions for Treatment Guidelines, Case Series, and Literature Review
🔗 Full article here: zurl.co/5fsg7
#BreastCancerAwarenessMonth #BreastCancerAwareness #BreastCancer #RadOnc #RadOncEd
Simran Polce, MD retweeted
With the support of the International Society for Therapeutic Radiology & Oncology (ISTRO), ACRO is providing up to 15 travel grants of $500 each to attend #ACRO2027!
Med students, residents and ACRO SEALs (#radonc leaders) who are ACRO members are invited to apply before Nov. 16.
Learn more and apply at acro.org/page/acro-travel-gr…
Simran Polce, MD retweeted
Happening now at #ASTRO26 Sarah Hoffe, MD moderates an insightful session on AI and digital allies for the clinical environment including quick pitches from experts including Moffitt’s Simran Polce, MD (@SimranPolce) #MoffittASTRO26
Simran Polce, MD retweeted
From #ASTRO26 this morning, Simran Polce, MD (@SimranPolce), shares findings on a patient-centered visual communication tool for telehealth that improved patient understanding and the virtual consultation experience, highlighting the potential of digital tools to strengthen communication in radiation oncology. #MoffittASTRO26
Simran Polce, MD retweeted
🙏 to all the @Applied_RadOnc editorial board members whose time and effort help to make this journal possible. Wonderful to have several #radonc residents at the board meeting #ASTRO2026 @ARRO_org @ACROresident #WomeninMedicine
Great to have the Applied Radiation Oncology Editorial Board together at #ASTRO26! Thank you to our board members for their time, insights, and continued contributions to ARO.
@ASTRO_org , @DrJohnSuh , @TeckieMD , @eaton_bree , @FaraDayani , @JessicaHossa , @PhDpingxia
#RadOnc #RadiationOncology #RadOncEd #ASTRO2026
Simran Polce, MD retweeted
Live from #ASTRO26: Emily Keit, MD (@Emily_R_Keit), moderates an education session on managing CNS metastases in critically ill patients, covering abbreviated whole-brain radiotherapy and SRS for dominant lesions in patients with poor performance status. #MoffittASTRO26
Simran Polce, MD retweeted
Happening at #ASTRO26: Join Simran Polce, MD (@SimranPolce) and Philippe Spiess, MD (@SpiessPhilippe) as they discuss patient-centered telehealth and multi-d care for rare GU cancers.
Learn more: moffitt.org/ASTRO
#MoffittASTRO26
Simran Polce, MD retweeted
From #ASTRO26, Kailey Gay stops by to discuss her Quick Pitch session on a structured, needs-based radiation oncology nursing curriculum designed to address gaps in specialty education. The initiative may serve as a model for other organizations facing similar educational needs. #MoffittASTRO26
Simran Polce, MD retweeted
From #ASTRO26, Roberto Diaz, MD (@RobertoDiazMD), chats with medical student John Wilson about an important question: Can some patients with early-stage breast cancer safely receive less treatment? Their research explores de-escalating endocrine therapy after APBI in select low-risk patients. #MoffittASTRO26
Simran Polce, MD retweeted
#ASTRO26 kicked off with ASTRO President Neha Vapiwala, MD (@NehaVapiwala ), welcoming attendees to Boston and highlighting the meeting by the numbers, including more than 1,700 poster presentations to come over the next several days. #MoffittASTRO26
Simran Polce, MD retweeted
Don’t miss Samantha Webking, MD, tomorrow at #ASTRO26 as she presents on burnout and retention risk among radiation therapists during departmental expansion.
#MoffittASTRO26 @ASTRO_org
Simran Polce, MD retweeted
Tomorrow at #ASTRO26, Simran Polce, MD (@SimranPolce), shares findings on preserving function with induction therapy while achieving high local control rates in locally advanced anal cancer.
#MoffittASTRO26 @ASTRO_org
Simran Polce, MD retweeted
We look forward to seeing you there! – at Macclenny, FL
The future of radiation oncology is on display at #ASTRO26. Moffitt is proud to be represented with more than 30 abstracts spanning breast, head and neck cancers, proton therapy, ctDNA and more.
Visit booth #2551 to meet our team and learn about the research that is redefining radiation oncology! #MoffittASTRO26
Explore our full presentation list:
bit.ly/3TjtgX7
Simran Polce, MD retweeted
Apparently posting #radonc memes can get you places. Thanks @MoffittNews for the recognition as a social media ambassador and the “Authentic Voice Award” 🥳
Simran Polce, MD retweeted
🚨#radonc trainees🚨
Abstracts for #ACRO2027 are now open! Great opportunity to present your work and meet others in the field.
See you in Las Vegas 😎🃏
We’ve opened the abstract submission portal for #ACRO2027 at acro.org/abstracts!
Your research belongs here, and we want to help you share it with the #radiationoncology community. 🩺📝
This is an outstanding opportunity for med students, residents, attending physicians, physicists, practice administrators and leaders from across the specialty to present research and advance patient care in a focused setting.
Head to our Annual Meeting landing page for full details on how to register and get involved: acro.org/annualmeeting
Simran Polce, MD retweeted
Calling all Anki lovers! 📢
The ACRO Resident Committee just dropped a brand new TNM Staging Anki deck to help you conquer your reviews. 🧠☢️
Grab it here (scroll down to 'Study Tools'): acro.org/page/MemberBenefits
Not an ACRO member yet? Join for free today for access and unbeatable networking! #RadOnc #MedTwitter #Anki #TNMStaging
Simran Polce, MD retweeted
ReRT is one of the hardest areas to plan and peer review: inspect fusions (some can't be trusted), evaluate cumulative dose, respect mobile OAR uncertainty, and use clinical judgment.
No calculator replaces that.
Feedback welcome. Hope this helps in clinic! #OncTwitter #RadOnc
ReRT planning is hard.
So we built a free EQD2-based D0.1cc calculator to help estimate remaining OAR reserve across prior RT courses, with both no-forgiveness and time-forgiveness options.
Decision support only. Use judgment. Verify independently.
#RadOnc #OncTwitter